Who
Kimberly J. Popovits
Director
Company insider
Files Form 4 as: Director, Kardigan; Director, 10x Genomics; Director, Kiniksa Pharmaceuticals International; Director, Rhythm Pharmaceuticals; Director, Exact Sciences; Interim CEO, Talis Biomedical; Director, MyoKardia; President and CEO, Genomic Health.
In numbers
- Trades disclosed
- 542
- Buys
- 2
- Sells
- 115
- Bought
- $106K
- Sold
- $41.9M
- Companies
- 10
- Companies where not an officer
- 8
- First trade
- 24 May 2006
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | KARD KardiganBiotechnology | SEC FORM 4 Code A | —20,706 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | KARD KardiganBiotechnology | SEC FORM 4 Code A | —20,706 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals InternationalBiotechnology | SEC FORM 4 Code M | —2,799 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —12,158 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —2,026 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —12,158 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —2,026 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —2,799 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —2,799 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | KNSA Kiniksa Pharmaceuticals InternationalBiotechnology | SEC FORM 4 Code M | —2,799 | filing |
| 1 Apr 2026filed 3 Apr 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,808 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,257 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,808 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | RYTM Rhythm Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,257 at $0.00 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact SciencesDiagnostics & Labs | SEC FORM 4 Code D | —6,725 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact SciencesDiagnostics & Labs | SEC FORM 4 Code D | —9,656 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciences | SEC FORM 4 Code D | —6,725 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciences | SEC FORM 4 Code D | —9,656 | filing |
The newest 500 lines are listed; the numbers count every line.
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.